爱尔眼科品牌怎么样 申请店铺

外推网助力爱尔眼科品牌出海！将品牌入驻外推网，定制爱尔眼科品牌推广信息，可以显著提高爱尔眼科产品曝光，简直是跨境电商爆单神器！目前仅需1000元/年哦~

湖南省著名商标，中国卫生产业理事会常务理事，我国较早IPO上市的医疗机构，有特色实力且规模较大的眼科医疗连锁机构

爱尔眼科医院集团是中国规模先进的眼科医疗连锁机构，IPO上市医疗机构(股票代码: 300015,2015年入选沪深300指数股)。截至2017年6月，已在全国30个省市区建立180余家专业眼科医院，覆盖全国医保人口超过70%，年门诊量超过400 万人。并且，在香港和美国也开设有眼科分支机构。

爱尔眼科致力于引进和吸收国际同步的眼科技术与医疗管理理念，以专业化、规模化、科学化为发展战略，推动中国眼科医疗事业的发展。

通过不断的探索与实践，并充分吸纳国际先进的医疗管理经验的基础上，成功探索出一套适应中国国情和市场环境的眼科医院连锁经营管理模式——“分级连锁”。利用人才、技术和管理等方面的优势，通过全国各连锁医院良好的诊疗质量、优质的医疗服务和专业的市场推广，使爱尔眼科成为全国各地眼科患者信赖的眼科医院。

2013年，爱尔眼科医院集团与中南大学联合成立专业的眼科医学院——中南大学爱尔眼科学院，主要培养眼科硕、博士高级医疗人才;2014年，再度与湖北科技大学联合成立爱尔眼视光学院。2011年和2015年，爱尔眼科先后成立“爱尔眼视光研究所”和“爱尔眼科研究所”。至此，爱尔眼科打通了眼科的医、学、研三大领域，学院和研究所的成立将使爱尔眼科的科研及临床水平得到显著提升，并以此推动中国眼科医疗事业的发展和进步。

截止2016年，爱尔眼科所属的专业眼科专家和医生团队达到近3000名，包括一大批硕士生导师、博士生导师、博士、博士后、留学欧美的学者以及临床经验丰富的核心专家，是中国眼科领域备受瞩目的有生力量。

2014年7月9日，世界银行行长金墉参观考察爱尔眼科长沙医院，并在全球发展中国家推广爱尔眼科独具特色的可持续公益慈善模式。2015年，爱尔眼科收购香港亚洲医疗集团，开启爱尔眼科国际化步伐，2017年，爱尔眼科收购美国知名眼科中心，国际化步伐再下一城。

爱尔眼科的发展壮大，始终以“使所有人，无论贫穷富裕，都享有眼健康的权利”为使命，追求社会责任和自身发展的和谐统一，通过开创性的“交叉补贴”模式，一方面为患者提供更高品质的眼科医疗服务，同时全面开展防盲治盲工作、投身社会公益和帮助弱势群体，并联合社会各界，推动整个中国防盲事业的全面发展。

随着中国医疗卫生体制改革的进一步推进，爱尔眼科顺应国家医疗卫生政策和发展趋势，于2014年在医疗行业推出“合伙人计划”，致力于改变眼科医生执业的生态环境，大限度地激发核心骨干的创造力和能动性。爱尔眼科专注于眼科医疗服务事业，预计到 2017年，兴建200家具有竞争力的专业连锁眼科医院，为更多的人提供高质量、多层次的眼科医疗服务。

Hunan famous trademark, executive director of China Health Industry Council, China's early IPO medical institutions, the eye medical chain with distinctive strength and large scale, Aier Eye Hospital Group is China's advanced eye medical chain, IPO medical institutions (Stock Code: 300015, selected in Shanghai and Shenzhen 300 index shares in 2015). As of June 2017, more than 180 professional ophthalmic hospitals have been established in 30 provinces and cities, covering more than 70% of the national medical insurance population and more than 4 million outpatients annually. In addition, there are also eye branches in Hong Kong and the United States. Aer ophthalmology is committed to introducing and absorbing the international synchronous ophthalmic technology and medical management concept, and promoting the development of China's ophthalmic medical cause with the development strategy of specialization, scale and scientization. Through continuous exploration and practice, and fully absorb the international advanced medical management experience, we have successfully explored a set of eye hospital chain management mode - "hierarchical chain" which is suitable for China's national conditions and market environment. With the advantages of talents, technology and management, and through the good diagnosis and treatment quality, high-quality medical services and professional marketing of chain hospitals across the country, aer ophthalmology has become the ophthalmic hospital trusted by ophthalmic patients all over the country. In 2013, Aier ophthalmic hospital group and Central South University jointly established a professional ophthalmic medical school - Aier ophthalmic College of Central South University, which mainly trains senior medical talents with master's degree and doctor's degree in Ophthalmology; in 2014, Aier ophthalmic college was jointly established again with Hubei University of science and technology. In 2011 and 2015, aer ophthalmology established "aer optometry Research Institute" and "aer ophthalmology Research Institute". So far, aer ophthalmology has opened up three major fields of Ophthalmology, namely, medicine, science and research. The establishment of the college and Research Institute will significantly improve the research and clinical level of aer Ophthalmology, and thus promote the development and progress of China's ophthalmic medical cause. As of 2016, the team of professional ophthalmologists and doctors affiliated to Aier ophthalmology has reached nearly 3000, including a large number of master's supervisors, doctoral supervisors, doctors, postdoctors, scholars studying in Europe and America and core experts with rich clinical experience. Aier ophthalmology is a high-profile and powerful force in the field of ophthalmology in China. On July 9, 2014, World Bank President Kim Yong visited Changsha hospital of Aier ophthalmology and promoted the unique sustainable charity model of Aier ophthalmology in developing countries around the world. In 2015, Aier ophthalmology acquired Hong Kong Asia Medical Group and started the pace of internationalization of Aier ophthalmology. In 2017, Aier ophthalmology acquired a famous American eye center, and the pace of internationalization will be another city. The development and expansion of Aier ophthalmology has always been based on the mission of "making all people, no matter rich or poor, enjoy the right to eye health", pursuing the harmonious unity of social responsibility and their own development. Through the pioneering "cross subsidy" model, on the one hand, it provides patients with higher quality eye medical services, and at the same time, it comprehensively carries out the work of blindness prevention and treatment, devotes itself to social public welfare and helps the weak We will work with all sectors of society to promote the all-round development of China's anti blindness cause. With the further promotion of China's medical and health system reform, aer Ophthalmology, in line with the national medical and health policy and development trend, launched the "partnership plan" in the medical industry in 2014, which is committed to changing the ecological environment for ophthalmologists to practice and greatly stimulating the creativity and initiative of core backbones. Aer ophthalmology focuses on ophthalmic medical services. It is expected that by 2017, 200 competitive professional chain ophthalmic hospitals will be built to provide more people with high-quality and multi-level ophthalmic medical services.

本文链接： https://brand.waitui.com/92f06e4a1.html 联系电话：请联系客服添加 联系邮箱：请联系客服添加